Express & Expedited Shipping Service
USD $92.50
AustraliaNexGard SPECTRA Chews for Large Dogs 15.1-30kg is a veterinary-approved, multi-spectrum treatment designed to protect your dog from a range of parasites. It offers comprehensive protection against fleas, ticks, heartworm, and intestinal worms, ensuring your pet stays healthy and parasite-free.
NexGard SPECTRA works by delivering a potent combination of active ingredients that target and eliminate parasites. The chews contain afoxolaner and milbemycin oxime, which work together to disrupt the nerve signals of parasites, effectively eliminating them and preventing infestations.
NexGard SPECTRA Chews should be given once a month. The chew can be administered directly to your dog or mixed with food. Ensure the entire dose is consumed for optimal efficacy. If a dose is missed, administer as soon as possible and resume the regular monthly schedule.
Consult your veterinarian before starting NexGard SPECTRA, especially if your dog is pregnant, lactating, or has a history of seizures. Monitor your dog for any adverse reactions, such as vomiting or diarrhea, and report these to your veterinarian. Keep out of reach of children and other animals.
NexGard SPECTRA is specifically formulated for large dogs weighing between 15.1-30kg. For dogs outside of this weight range, consult your veterinarian for appropriate alternatives. Always adhere to the recommended dosage guidelines to ensure safety and effectiveness.
Health Guides
Nov 06, 2026
Medication dry mouth happens when a drug reduces saliva production or alters the sensation of moisture. Anticholinergic effects are a common cause, and management usually combines a medication review, moisture replacement and tooth protection. Persistent dryness can make eating or speaking difficult
Nov 05, 2026
Blood pressure medicines can cause dizziness on standing because they reduce the body's ability to maintain pressure against gravity. The resulting drop can briefly reduce blood flow to the brain, a condition called orthostatic hypotension. Blood pressure medication dizziness often appears after t
Nov 04, 2026
Biotin supplements can interfere with thyroid and heart blood tests, producing falsely high or unexpectedly low results. This interference affects certain laboratory methods rather than the actual hormone or cardiac-marker concentration being measured. The greatest danger is a falsely low troponin r
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 31, 2026
Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 29, 2026
Serotonin syndrome is a potentially life-threatening drug reaction caused by excessive serotonin activity. Fever, confusion, and muscle jerking after a medicine change require urgent medical assessment. Symptoms often begin within hours, particularly when medicines with overlapping serotonin effects
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 27, 2026
Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery
